BriaCell Therapeutics (BCTX) to Release Earnings on Friday

BriaCell Therapeutics (NASDAQ:BCTX) is expected to be issuing its quarterly earnings data before the market opens on Friday, June 13th. Analysts expect the company to announce earnings of ($1.76) per share for the quarter.

BriaCell Therapeutics (NASDAQ:BCTX) last posted its quarterly earnings results on Monday, March 17th. The company reported ($2.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.94) by ($0.39). On average, analysts expect BriaCell Therapeutics to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

BriaCell Therapeutics Trading Down 0.3%

BriaCell Therapeutics stock opened at $3.47 on Wednesday. The business has a 50-day moving average of $3.81 and a 200-day moving average of $5.74. BriaCell Therapeutics has a 1 year low of $2.81 and a 1 year high of $29.40. The firm has a market capitalization of $12.87 million, a P/E ratio of -0.26 and a beta of 1.30.

Analyst Ratings Changes

Separately, HC Wainwright restated a “buy” rating and issued a $32.00 price objective on shares of BriaCell Therapeutics in a research report on Tuesday, April 22nd.

About BriaCell Therapeutics

BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer.